Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polyneuropathies”

862 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 862 results

Post-approval studies (Phase 4)Study completedNCT02260388
What this trial is testing

Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations

Who this might be right for
Cryptogenic Sensory Polyneuropathy
University of Kansas Medical Center 402
Early research (Phase 1)Ended earlyNCT02292225
What this trial is testing

Duvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY)

Who this might be right for
Lymphocytic Leukemia, ChronicLymphoma, Small Lymphocytic
SecuraBio 3
Testing effectiveness (Phase 2)Study completedNCT04396496
What this trial is testing

Treatment of POEMS Syndrome With Daratumumab

Who this might be right for
POEMS Syndrome
University of Arkansas 2
Not applicableNo Longer AvailableNCT03317366
What this trial is testing

Expanded Access to Provide ARQ 092 for the Treatment of Overgrowth Diseases and/or Vascular Anomalies

Who this might be right for
Proteus SyndromePIK3CA-Related Overgrowth Spectrum (PROS)Growth Disorders
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Early research (Phase 1)Ended earlyNCT04800822
What this trial is testing

PF-07284892 in Participants With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Pfizer 53
Post-approval studies (Phase 4)Study completedNCT06637072
What this trial is testing

Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SC

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
argenx 23
Testing effectiveness (Phase 2)Study completedNCT01733407
What this trial is testing

L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1

Who this might be right for
Hereditary Sensory and Autonomic Neuropathy Type I
Massachusetts General Hospital 18
Not applicableLooking for participantsNCT06183645
What this trial is testing

Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Centre Hospitalier Universitaire de Liege 40
Large-scale testing (Phase 3)Study completedNCT01886495
What this trial is testing

Effect of High Protein Diet on Adiponectin and Inflammation Among Overweight and Obese Children

Who this might be right for
Body Mass Index Quantitative Trait Locus 5 DisorderTangier Disease
Isfahan University of Medical Sciences 50
Not applicableUnknownNCT02722070
What this trial is testing

Processing Integration in Neurological Patients Using fMRI

Who this might be right for
Acute Inflammatory Demyelinating PolyradiculoneuropathyStrokeAnosognosia+2 more
Hadassah Medical Organization 150
Not applicableLooking for participantsNCT06968975
What this trial is testing

Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)

Who this might be right for
Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi 200
Testing effectiveness (Phase 2)Study completedNCT02595983
What this trial is testing

The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant

Who this might be right for
Transthyretin (TTR)-Mediated AmyloidosisFamilial Amyloidotic Polyneuropathy (FAP)ATTR Amyloidosis+1 more
Alnylam Pharmaceuticals 12
Not applicableUnknownNCT04303962
What this trial is testing

Efficacy of Intravenous Gamma Globulin on Guillain-Barre Syndrome

Who this might be right for
Guillain-barre Syndrome
Ning Wang, MD., PhD. 200
Not applicableLooking for participantsNCT04850105
What this trial is testing

A Non-interventional Cohort Safety Study of Patients With hATTR-PN

Who this might be right for
Hereditary Transthyretin Amyloidosis With Polyneuropthy
Akcea Therapeutics 240
Not applicableStudy completedNCT02629796
What this trial is testing

Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Who this might be right for
CIDP
Fondation Ophtalmologique Adolphe de Rothschild 44
Not applicableUnknownNCT05940922
What this trial is testing

RWE-based Treatment Patterns and Outcomes in CIDP

Who this might be right for
Chronic Inflammatory Demyelinating PolyneuropathyGuillain-Barre SyndromeHereditary Amyloidosis
RwHealth 170
Not applicableStudy completedNCT05373082
What this trial is testing

Identification of Modifying Factors in Hereditary Spastic Paraplegia

Who this might be right for
Hereditary Spastic Paraplegia
Assistance Publique - Hôpitaux de Paris 311
Not applicableStudy completedNCT02947828
What this trial is testing

Polyneuropathy in Diabetes Mellitus Type 2

Who this might be right for
Diabetes Mellitus Type 2 Without ComplicationPolyneuropathies, DiabeticDiabetes Complications+2 more
Danish Pain Research Center 490
Large-scale testing (Phase 3)Study completedNCT00927914
What this trial is testing

Evaluating the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy

Who this might be right for
Mild to Moderate Diabetic Sensorimotor Polyneuropathy
Eisai Inc. 800
Testing effectiveness (Phase 2)Active Not RecruitingNCT06433219
What this trial is testing

Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

Who this might be right for
Ovarian Cancer
EMD Serono Research & Development Institute, Inc. 63
Load More Results